Demodex TARSUS Demodex

Book an Appointment

ACTIVE STUDY

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

Disease/Condition

Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation

Status

Active

Description

The purpose of this study is to compare the safety and efficacy of TP-03, 0.25%, an eyedrop, BID vs TID dosing regimens for the treatment of meibomian gland dysfunction in patients with Demodex lid infestation.

This Phase 2a study is a randomized, two-arm, double-masked, multicenter, parallel pilot study to compare the safety and efficacy of two dosing regimens of TP-03, BID vs TID, for the treatment of meibomian gland dysfunction in patients with Demodex lid infestation. The primary objective of the study is to assess the safety and efficacy of two dosing regimens of TP-03, 0.25% from Day 1 to Day 85 in adult participants with meibomian gland dysfunction in the presence of Demodex infestation. Efficacy will be determined by assessing lower lid meibomian gland secretion, lid margin erythema, bulbar redness, tear breakup time, ocular surface staining, and dry eye symptoms.

Patient Benefit

Possible testing and treatment at no cost.

Patient Compensation

Up to $600 depending on participation level.

Participation Criteria

Inclusion Criteria:

  • Must be 18 years of age or older.
  • Be willing to sign the informed consent and deemed capable of complying with the requirements of the study prototcol
  • Meets all of the following criteria in at least on eye: have more than 10 lashes with collarettes present on the upper lid; have the presence of one or more mites in the upper and lower lids; have evidence of meibomian gland dysfunction; have at least mild erythema of the lower lid; have tear breakup time of less than 10 seconds; and have intact partial to full meibomian glands in at least 33% of the total meibomian gland area of the lower lid

Exclusion Criteria:

  • Have used lid hygiene products within 7 days of Day 1 or unwilling to forego the use of lid hygiene products during the study
  • Have used systemic antihistamines within 30 days of Day 1
  • Have used artificial eyelashes, eyelash extensions or had other cosmetic eyelash or eyelid procedures within 7 days of Day 1 or be unwilling to forego their use during the study
  • Contact lens wear within 7 days of Day 1 or unwilling to forego contact lens wear for the duration of the study
  • Be pregnant or lactating at Day 1

Study Dates

July 2022 – TBD

Study Sponser

TARSUS

Horsham, PA

303 Horsham Rd, Suite G (Top Floor, Entrance next to Mathnasium) Horsham, PA 19044

Phone: 267-965-2599

Fax: 267.965.2598

Contact Us Learn More About Location

Newtown Square, PA

3475 West Chester Pike, Suite 100 Newtown Square, PA 19073

Phone: 610-422-7999

Fax: 610.422.7988

Contact Us Learn More About Location

Shrewsbury, PA

781 Far Hills Drive Suite 100 New Freedom, PA 17349

Phone: 717-759-5929

Fax: 717.563.0348

Contact Us Learn More About Location

Our Testimonials

Our Blog

Family History, Ethnic Background and Age All Drive Increased Glaucoma Risk

Eye Conditions & Diseases

Family History, Ethnic Background and Age All Drive Increased Glaucoma Risk

Eye Conditions & Diseases

Are you more at risk for glaucoma than you realize? Glaucoma is one of the leading causes of preventable blindness in the world. Most surprisingly, of the estimated three million Americans who suffer from Glaucoma, more than 50% are not even aware they have it!Despite a lack of noticeable symptoms, there are several important risk […]

Read More… from Family History, Ethnic Background and Age All Drive Increased Glaucoma Risk

January 11, 2023
0
Medical Optometry America

Are you more at risk for glaucoma than you realize? Glaucoma is one of the leading causes of preventable blindness in the world. Most surprisingly, of the estimated three million Americans who suffer from Glaucoma, more than 50% are not even aware they have it! Despite a lack of noticeable symptoms, there are several important […]

Read More… from Family History, Ethnic Background and Age All Drive Increased Glaucoma Risk

Powerful Relief for Dry Eye and Other Ocular Surface Conditions

Dry EyeEye Conditions & Diseases

Powerful Relief for Dry Eye and Other Ocular Surface Conditions

Dry EyeEye Conditions & Diseases

Many people suffer from chronic, recurrent eye pain and blurry vision caused by advanced Dry Eye Disease and other ocular surface conditions that cause inflammation. In many instances, treatments such as drops, ointments, and prescription drugs provide temporary relief, but fail to provide lasting, long-term recovery patients need. One leading-edge treatment option for these patients […]

Read More… from Powerful Relief for Dry Eye and Other Ocular Surface Conditions

December 20, 2022
0
Medical Optometry America

Many people suffer from chronic, recurrent eye pain and blurry vision caused by advanced Dry Eye Disease and other ocular surface conditions that cause inflammation. In many instances, treatments such as drops, ointments, and prescription drugs provide temporary relief, but fail to provide lasting, long-term recovery patients need. One leading-edge treatment option for these patients […]

Read More… from Powerful Relief for Dry Eye and Other Ocular Surface Conditions

Dr. Leslie O’Dell Honored with National Award

Medical Optometry America in the NewsNewsOptometry Business

Dr. Leslie O’Dell Honored with National Award

Medical Optometry America in the NewsNewsOptometry Business

Dr. O’Dell recognized with Theia Award from Women in Optometry in the Innovation Category for her pioneering work in medical Optometry Each year, national publication Women in Optometry selects female leaders in the eye care field to honor with its Theia Awards. This year, Dr. Leslie O’Dell, FAAO, Medical Director for MOA – Shrewsbury was […]

Read More… from Dr. Leslie O’Dell Honored with National Award

December 9, 2022
0
Medical Optometry America

Dr. O’Dell recognized with Theia Award from Women in Optometry in the Innovation Category for her pioneering work in medical Optometry Each year, national publication Women in Optometry selects female leaders in the eye care field to honor with its Theia Awards. This year, Dr. Leslie O’Dell, FAAO, Medical Director for MOA – Shrewsbury was […]

Read More… from Dr. Leslie O’Dell Honored with National Award

Follow Us

instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star star-half chevron-right chevron-left chevron-down chevron-up envelope fax